Global Artificial Pancreas Device System (APDS) Market, By Technology (Threshold Suspended Device Systems, Treat to Range/Control to Range (TTR/CTR), Treat to Target/ Control to Target (TTR/CTT)), Distribution Channel (E-commerce, Standalone Retail Shops, Hospitals), End User (Type 1 Diabetic Patients, Type 2 Diabetic Patients), and Geography - Trends, Analysis and Forecast till 2024

Artificial Pancreas Device System (APDS) – Putting the Ease in Diabetes Management

Administering insulin on daily basis is cumbersome for type 1 diabetes (T1D) patients in a busy lifestyle. While devices such as insulin pumps, pens, and jet injectors have made living with diabetes less stressful by ridding users of relatively painful insulin delivering devices such as needles and syringes. Juvenile Diabetes Research Foundation (JDRF) is working in collaboration with many industry players such as Medtronic, Inc., Johnson & Johnson, and Tandem Diabetes Care, Inc. to develop innovative insulin and glucose monitoring systems/devices.

Artificial pancreas is the outcome of these collaborations which is also encouraged for use by the FDA. Artificial pancreas device system (APDS) consists of an insulin pump, sensor, transmitter, and a receiver. MiniMed 530G from Medtronic, Inc. was the first artificial pancreas device system (APDS) approved by FDA. This threshold suspend device system enables temporary suspension of insulin delivery when the glucose level is lower than the threshold level. Another system, Medtrum’s P6 Easy Touch Disposable Pump is a semi-closed loop artificial pancreas that is under clinical trials in Europe. Many such systems are under clinical trials and expected to be launched in near future in the global artificial pancreas device system (APDS) market. Developed economies in North America, Europe and Pacific region would be the potential regional opportunities for this novel system in the global artificial pancreas device system (APDS) market.

Category

Product

Company/Institute

Status

Expected launch

Threshold Suspended Device Systems

 

t:slim

Tandem

XX

XX

Treat to Range/Control to Range (TTR/CTR)

 

Animas pump

Animas Corporation

XX

XX

Treat to Target/ Control to Target (TTR/CTT)

Insulin-only

iLet

Beta Bionics

FDA submission by 2017 end

XX

XX

XX

XX

XX

XX

XX

XX

XX

Hybrid systems

MiniMed 670G

Medtronic

FDA Approved

Apr-17

XX

XX

XX

 

XX

XX

XX

XX

Bi-hormonal systems

iLet

Beta Bionics

FDA submission potentially in 2019.

 

XX

XX

XX

 

XX

XX

XX

 

The global artificial pancreas device system (APDS) market was valued at US$ 64.0 million in 2015 and is expected to witness a moderate CAGR of 18.6% during the forecast period (2016 – 2024).

Figure 1. Global Artificial Pancreas Device System (APDS) Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024

Artificial Pancreas Devices System Market

Source: Coherent Market Insights Analysis (2017)

To have a snippet of the report, request Report Sample

Technological advancements to drive growth of the global artificial pancreas device system (APDS) market

In 2016, the U.S. FDA approved a hybrid closed-loop artificial pancreas device system (APDS) MiniMed 670G which is an automated system. The continuous glucose monitor in the system automatically sends signals to the insulin pump to deliver insulin when the glucose level in body goes beyond the acceptable limit. Thus, there is no need for the user to stimulate the release of insulin every time the glucose level is abnormal. This provide the user freedom to perform his/her daily activities. Such advancement in T1D management is expected to be highly preferred by the users and medical community, leading to higher advocacy to use this device especially among the patient group using insulin pumps. Moreover, in mid-2018, a study will test a bihormonal “bionic pancreas” system at the Massachusetts General Hospital (Boston) and Boston University. This would further fuel the artificial pancreas device system (APDS) market growth and attract more investments.

Strategic collaborations fostering artificial pancreas device system (APDS) market growth

There were over 20 projects undertaken by the industry payers in 2015 with respect to development of artificial pancreas device system (APDS). Bigfoot Biomedical acquired Asante’s FDA approved Snap insulin pump technology in 2015 and at the same time signed a development agreement with Dexcom to integrate Dexcom’s CGM in its under development artificial pancreas device system (APDS). Dexcom is in collaboration with many other market players such as Insulet Corporation, Animas Corporation, and International Diabetes Closed Loop wherein, these companies would be incorporating Dexcom’s CGM in their artificial pancreas device system (APDS). Such collaborations are expected to expedite market entry for new artificial pancreas device system (APDS)s and thus drive the growth of artificial pancreas device system (APDS) market.

Lack of reimbursement to hinder artificial pancreas device system (APDS) market growth

The prevalence of T1D in the U.S. is 1.35 million which is expected to increase to 5 million by 2050 as per the estimates (2016) by JDRF. Each year 40,000 people are diagnosed with T1D in the U.S. according to the JDRF. With this huge patient base, potential opportunity for artificial pancreas device system (APDS) looks considerably high at global level. However, lack of reimbursement for glucose sensors is expected to inhibit the uptake of artificial pancreas device system (APDS). With an average cost of US$ 6000-7000, adoption of artificial pancreas device system (APDS) is estimated to be restricted among rich T1D patients. Furthermore, only a few T1D patient group prefer insulin pumps for treatment. According to the 2013 report of JDRF, about 350,000 insulin pumps were sold in the U.S. Thus, creating awareness should also be an objective of artificial pancreas device system manufacturers to increase its adoption.

Eating habits of type 1 diabetes patients is highly curtailed, complemented by regular administration of insulin. Type 1 diabetes patients require multiple doses of insulin in a day and all-round the year. Advancements in research and technology has led to commercialization of easy-to-us insulin delivery systems such as insulin pens, pumps, inhaled insulin, and injectors. Use of syringes to deliver insulin has become obsolete with the introduction of advanced and easy-to-use insulin delivery systems mentioned above. Moreover, these systems offer the convenience to self-administer insulin at home. An artificial pancreas is a novel concept that promises to revolutionize the entire diabetes market. The system automatically detects glucose level in patient’s blood or plasma and accordingly administers the necessary dosage of insulin. Medtronic’s MiniMed 670G is one such wearable artificial pancreas. The system is automated to monitor glucose levels and deliver insulin through an insulin pump attached to the system. The artificial pancreas system comprises a transmitter, sensor, and insulin pump. This helps in continuous monitoring and diabetes management at ease.

Market Dynamics

The artificial pancreas device system (APDS) market growth would be mainly driven by increasing adoption of the highly useful systems the large base of diabetes type 1 patients, further supplemented by ever increasing incidence of type 1 diabetes. According to the World Health Organization (WHO), number of diabetes patients worldwide increased from 108 million in 1980 to 422 million in 2014. According to Juvenile Diabetes Research Foundation (JDRF), there were around 1.5 million type 1 diabetics worldwide in 2015. JDRF funds research in diabetes 1 and the non-profit organization expected the first artificial pancreas to be commercialized in 2017. According to the Center for Disease Control and Prevention (CDC), type 1 diabetes accounts for around 5% of the total diagnosed diabetes cases in adults in the U.S. Developed regions are expected to dominate the artificial pancreas device system (APDS) market size, as these regions are early adopters of disruptive technologies. With the introduction of this technology, market for insulin pens and injectors is expected to be impacted negatively.

Market Taxonomy

This report segments the global artificial pancreas device system (APDS) market on the basis of technology, distribution channel, end user and geography. On the basis of technology, the global artificial pancreas device system (APDS) market is categorized into Treat to Range/Control to Range (TTR/CTR), Treat to Target/ Control to Target (TTR/CTT) and Threshold Suspended Device Systems. On the basis of distribution channel the global artificial pancreas device system (APDS) market is segmented into e-commerce, Standalone Retail Shops and hospitals. End user of the APDS include type 1 and type 2 diabetic patients. For comprehensive understanding of market dynamics, the global artificial pancreas device system (APDS) market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Request Report Sample for more Professional and Technical Insights.

Key features of the study:

  • This report provides in-depth analysis of the artificial pancreas systems and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global artificial pancreas device system (APDS) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Medtronic, Medtrum, Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, and Insulet Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
  • The global artificial pancreas device system (APDS) market report caters to various stakeholders in this industry, including investors, manufacturers and distributors for artificial pancreas system and components, end users, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the artificial pancreas device system (APDS) market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Artificial Pancreas Device System (APDS) Market, By Technology:
    • Threshold Suspended Device Systems
    • Treat to Range/Control to Range (TTR/CTR)
    • Treat to Target/ Control to Target (TTR/CTT)
  • Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
    • E-commerce
    • Standalone Retail Shops
    • Hospitals      
  • Global Artificial Pancreas Device System (APDS) Market, By End User:
    • Type 1 Diabetic Patients
    • Type 2 Diabetic Patients
  • Global Artificial Pancreas Device System (APDS) Market, By Geography:
    • North America
      • U.S.
        • U.S. Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • U.S. Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • U.S. Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Canada
        • Canada Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Canada Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Canada Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
    • Europe
      • U.K.
        • U.K. Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • U.K. Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • U.K. Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Germany
        • Germany Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Germany Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Germany Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Italy
        • Italy Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Italy Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Italy Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • France
        • France Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • France Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • France Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Spain
        • Spain Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Spain Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Spain Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Russia
        • Russia Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Russia Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Russia Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Rest of Europe
        • Rest of Europe Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Rest of Europe Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Rest of Europe Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
    • Asia-Pacific
      • China
        • China Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • China Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • China Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • India
        • India Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • India Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • India Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Japan
        • Japan Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Japan Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Japan Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • ASEAN
        • ASEAN Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • ASEAN Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • ASEAN Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Australia
        • Australia Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Australia Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Australia Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • South Korea
        • South Korea Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • South Korea Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • South Korea Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Rest of Asia Pacific (APAC)
        • Rest of Asia Pacific Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Rest of Asia Pacific Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Rest of Asia Pacific Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
    • Latin America
      • Brazil
        • Brazil Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Brazil Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Brazil Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Mexico
        • Mexico Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Mexico Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Mexico Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Argentina
        • Argentina Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Argentina Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Argentina Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Rest of Latin America
        • Rest of Latin America Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Rest of Latin America Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Rest of Latin America Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
    • Middle East
      • GCC
        • GCC Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • GCC Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • GCC Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Israel
        • Israel Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Israel Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Israel Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Rest of Middle East
        • Rest of Middle East Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Rest of Middle East Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Rest of Middle East Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
    • Africa
      • North Africa
        • North Africa Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • North Africa Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • North Africa Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • Central Africa
        • Central Africa Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • Central Africa Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • Central Africa Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
      • South Africa
        • South Africa Artificial Pancreas Device System (APDS) Market, By Technology:
          • Threshold Suspended Device Systems
          • Treat to Range/Control to Range (TTR/CTR)
          • Treat to Target/ Control to Target (TTR/CTT)
        • South Africa Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
          • E-commerce
          • Standalone Retail Shops
          • Hospitals
        • South Africa Artificial Pancreas Device System (APDS) Market, By End User:
          • Type 1 Diabetic Patients
          • Type 2 Diabetic Patients
  • Company Profiles
    • Medtronic*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Medtrum
    • Tandem Diabetes Care, Inc.
    • Johnson & Johnson
    • Beta Bionics
    • Bigfoot Biomedical
    • Insulet Corporation
    • Pancreum, Inc.
    • TypeZero Technologies, Inc.
    • DreaMed Diabetes Ltd
    • Inreda Diabetic BV

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Technology
      • Market Snippet By Distribution Channel
      • Market Snippet By End User
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Supply Side Drivers
        • Demand Side Drivers
        • Economic Drivers
      • Restraints
      • Market Opportunities
      • Technology Assessment
      • Reimbursement and Regulatory Scenario
      • Merger and Acquisitions/Collaborations
      • Product Pipeline Analysis
      • Pricing Analysis
  4. Global Artificial Pancreas Device System (APDS) Market, By Technology, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Threshold Suspended Device Systems
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Treat to Range/Control to Range (TTR/CTR)
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Treat to Target/ Control to Target (TTR/CTT)
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  5. Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • E-Commerce
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Standalone Retail Shops
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  6. Global Artificial Pancreas Device System (APDS) Market, By End User, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Type 1 Diabetic Patients
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Type 2 Diabetic Patients
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  7. Global Artificial Pancreas Device System (APDS) Market, By Regions, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, For Regions, 2014 - 2024
    • North America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Europe
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • France
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Europe
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Asia Pacific
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • China
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • India
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Asia Pacific
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Latin America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Argentina
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Latin America
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Middle East
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • GCC Countries
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Middle East
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million))
    • Africa
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Medtronic
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Medtrum
        • Company Overview
        • Product Portfolio
        • Recent Developments/Updates
        • Future Plans
      • Tandem Diabetes Care, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Beta Bionics
        • Company Overview
        • Product Portfolio
        • Recent Developments/Updates
        • Future Plans
      • Bigfoot Biomedical 
        • Company Overview
        • Product Portfolio
        • Recent Developments/Updates
        • Future Plans
      • Insulet Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Pancreum, Inc.
        • Company Overview
        • Product Portfolio
        • Recent Developments/Updates
        • Future Plans
      • TypeZero Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Recent Developments/Updates
        • Future Plans
      • DreaMed Diabetes Ltd
        • Company Overview
        • Product Portfolio
        • Recent Developments/Updates
        • Future Plans
      • Inreda Diabetic BV
        • Company Overview
        • Product Portfolio
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 90 market data tables and 40 figures on "Artificial Pancreas Device System (APDS) Market - Global forecast to 2024”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

sales@coherentmarketinsights.com

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.